Purchase Order 75F40124P00215
Award Date 6/7/24
Potential Completion Date 9/30/24
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for $24,357.60 to provide PacBio reagents. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by federal agencies like the FDA, CDC, USDA, and NIH to support genomic research across...
- This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025. Pacific Biosciences is the original equipment manufacturer for the...
- This federal contract award to Pacific Biosciences of California, Inc. (PacBio) provides for the delivery of a PacBio RS DNA sequencing system with a 12-month service contract. The $998,000.00 firm fixed price contract was awarded by the Food and Drug Administration (FDA), a civilian agency, without the use of a set-aside. PacBio is the original equipment manufacturer for the PacBio Sequel and Sequel II sequencing platforms, which are in high demand across federal agencies for genomic research...
- This is a purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. The contract is for $138,848.00 and is a firm fixed price agreement. The contract provides Pacific Biosciences, a manufacturer of scientific equipment, reagents, and services, the opportunity to deliver their proprietary Sequel and Sequel II DNA/RNA sequencing systems, along with associated consumables and software, to...
- This is a firm fixed-price delivery order contract awarded by the Plains Area division of a civilian federal agency to Pacific Biosciences of California, Inc. for PACBIO sequencing supplies. The $97,560.96 contract has an ultimate completion date of December 31, 2025 and was not set aside. Pacific Biosciences is a biotechnology company that specializes in advanced DNA and RNA sequencing technologies, primarily the Sequel and Sequel II platforms. The company has been awarded multiple contracts by...
- The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
- This federal contract award is for the delivery of PACBIO REAGENT KITS, including all reagents for sequencing 24 REVIO SMRT cells (quantity 8) and associated library prep reagents. The contract was awarded to Pacific Biosciences of California, Inc., a for-profit biotechnology company specializing in advanced DNA and RNA sequencing technologies. The contract has a ceiling value of $232,853.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 30, 2026. The...
- This federal contract award was made by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The $158,720.18 purchase order is for the addition of items from Requisition #1199385, with a completion date of October 30, 2018. This contract is a firm-fixed price award and was set aside for small businesses. Pacific Biosciences has...
- The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...